Testing effectiveness (Phase 2)Study completedNCT02869347
What this trial is testing
Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects
Who this might be right for
Acute Kidney Injury
University Hospital, Basel, Switzerland 80